Map of Pancreatica Walks and Runs

Author Archives: pancreatica

Including Grade Status Marker Levels in the Staging of Neuroendocrine Tumors

In a sense, the pancreatic cancer research underlying this blog posting is a bookend to the one that we discussed here in the Pancreatica Blog about a month ago.  Then, researchers had incorporated the Ki-67 cell proliferation marker into a standard Tumor-Node-Metastasis system (American Joint Committee on Cancer – AJCC) to see if the novel […]

Share Button

More Information in the Adjuvant Chemoradiation Controversy for Pancreatic Adenocarcinoma

The findings of the European Study Group for Pancreatic Cancer (ESPAC-1) clinical trial and championed by surgeon John Neoptolemos of Liverpool University more than a decade ago challenged the assumption that chemotherapy combined with radiation was a superior regimen after pancreatic cancer surgery.  The chemotherapy alone arm of this trial (using bolus 5-fluorouracil with folinic […]

Share Button

Daniel Von Hoff Inducted into Lederberg Society for Work on Abraxane in Pancreatic Cancer

One of our favorite physician pancreatic cancer researchers, Daniel Von Hoff, has been honored by induction into the Joshua Lederberg Society on February 13, 2014 primarily for his work in shepherding the development of Abraxane (nab-paclitaxel) in combination with gemcitabine for the treatment of advanced cancer of the pancreas. This award is presented by Celgene […]

Share Button